Arix Bioscience Plc - 2019 Capital Markets Day
2019 Capital Markets Day
Oncology Portfolio Spotlight
(“Arix”, LSE: ARIX) a global venture capital company focused on investing in and building breakthrough biotech companies, is hosting its 2019 Capital Markets Day from today Thursday, 3 in ., :
The Capital Markets Day, focused on Arix’s oncology portfolio, will be an opportunity for institutional investors, analysts and media to learn more about Arix, its portfolio companies and strategy.
The event will include presentations from Joe Anderson, Chief Executive Officer and Jonathan Tobin, Investment Director, along with presentations from the oncology portfolio companies, a panel discussion and Q&A.
No new material information will be disclosed.
Presenters at the Arix Capital Markets Day will include:
Registration for the event will start at followed by a series of presentations and Q&A sessions starting promptly from . The day will conclude with a networking session from approximately .
A webcast of the event, with presentation slides, will be available on the Arix after the event.website
For more information on Arix, please contact:
, Head of Investor Relations
+44 (0)20 7290 1072
T: +44 (0) 203 950 9144
is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences.
We collaborate with exceptional entrepreneurs and provide the capital, expertise and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors.
-- , PhD, CEO of -- , PhD, Investment Director, -- , PhD, Entrepreneur in Residence, and Executive Chairman, -- los Pinos, PhD, CEO of Aura Biosciences -- , PhD, CEO and Chairman of (NASDAQ: AUTL) -- , President and CEO of VelosBio -- , PhD, CEO of Artios Pharma -- , PhD, President and CEO of (NASDAQ: HARP)
Joe Anderson Jonathan Tobin Christian Schetter STipe Therapeutics Elisabet de Christian Itin Dave Johnson Niall Martin Gerald McMahon Arix Bioscience plc Arix Bioscience plc Arix Bioscience plc Autolus Harpoon Therapeutics
Quick facts: Arix Bioscience PLC
Market Cap: £117.3 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE